HALO logo
halo search icon
CSL
CSL Limited

CSL · CSL Limited

114.22

AUD
-1.53 (-1.322%)
24/07/2026 04:11:02 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$55.43B

PE

25.00

EV/EBITDA

17.2

DIV Yield

1.9%

Franking

0%

MQV Rating

4Weak

As at 24/07/2026 04:11:02 PM

Price Chart

Description

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

  • All-Companies
  • All-Consensus
  • ALL-Recommendations
  • ASR Trading Report - All
  • Falling DPS over 2yrs
  • GROWTH AUS
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO Capital Efficiency
  • HALO Ords
  • HALO Value

Key Fundamentals

EPS 3 yr Growth

28.90%

EBITDA Margin

32.70%

Operating Cashflow

$3,561m

Free Cash Flow Return

12.40%

ROIC

10.50%

Interest Coverage

11.30

Quick Ratio

1.10

Performance

52 weeks range

Low 90 - 275.79

Trade Value (12mth)

US$37,917,361.00

1 week

-7.38%

1 month

-0.57%

YTD

-33.58%

1 year

-57.87%

All time high

342.75

Additional Data

Shares Outstanding (Fully Diluted)

486m

HALO Sector

Healthcare

Next Company Report Date

18-Aug-26

Next Ex Dividend Date

10-Mar-26

Next Dividend Pay Date

09-Apr-26

Reporting Currency

USD

Short Sell (% of issue)

0.97

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Weak

Mqv Small

Neutral

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
07 July 26ASXD
29 June 26ASXD
09 June 26ASXD
05 June 26ASXD
03 June 26ASXD

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of CSL Limited (CSL:ASX)?
Halo FAQ
The current share price of CSL Limited (CSL:ASX) is AUD$114.22.
2
What is the 52-week high share price for CSL Limited (CSL:ASX)?
Halo FAQ
The 52-week high share price for CSL Limited (CSL:ASX) is AUD$275.79.
3
What is the 52-week low share price for CSL Limited (CSL:ASX)?
Halo FAQ
The 52-week low share price for CSL Limited (CSL:ASX) is AUD$90.00.
4
What is the dividend yield for CSL Limited (CSL:ASX)?
Halo FAQ
The current TTM dividend payout for CSL Limited (CSL:ASX) is 1.90.
5
What was CSL Limited (CSL:ASX) last dividend payment?
Halo FAQ
The last dividend payment of CSL Limited (CSL:ASX) is AUD$1.81.
6
What is the franking level for CSL Limited (CSL:ASX)?
Halo FAQ
CSL Limited (CSL:ASX) has a franking level of 0.00%.
7
In which sector is CSL Limited (CSL:ASX) classified?
Halo FAQ
CSL Limited (CSL:ASX) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for CSL Limited (CSL:ASX)?
Halo FAQ
The current P/E ratio for CSL Limited (CSL:ASX) is 25.00.